ID   PER-494
AC   CVCL_A8JU
DR   Wikidata; Q108821103
RX   PubMed=33937032;
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=33937032
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D21S11: 30.2,31.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 15,16
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W984 ! PER-485
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
RX   PubMed=33937032; DOI=10.3389/fonc.2021.631594; PMCID=PMC8082024;
RA   Cheung L.C., de Kraa R., Oommen J., Chua G.-A., Singh S., Hughes A.M.,
RA   Ferrari E., Ford J., Chiu S.K., Stam R.W., Kees U.R., Malinge S.,
RA   Kotecha R.S.;
RT   "Preclinical evaluation of carfilzomib for infant KMT2A-rearranged
RT   acute lymphoblastic leukemia.";
RL   Front. Oncol. 11:631594.1-631594.13(2021).
//